Polyamines: The possible missing link between mental disorders and epilepsy (Review)

Baroli,Giulia; Sanchez,Jonathan   Reinoso; Agostinelli,Enzo; Mariottini,Paolo; Cervelli,Manuela

doi:10.3892/ijmm.2019.4401

January-2020 Volume 45 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

January-2020 Volume 45 Issue 1

Full Size Image

Review

Polyamines: The possible missing link between mental disorders and epilepsy (Review)

Authors:
- Giulia Baroli
- Jonathan Reinoso Sanchez
- Enzo Agostinelli
- Paolo Mariottini
- Manuela Cervelli
View Affiliations / Copyright

Affiliations: Department of Science, University of Rome ‘Roma Tre’, I‑00146 Rome, Italy, Department of Biochemical Sciences ‘Rossi Fanelli’, University of Rome ‘La Sapienza’, I‑00185 Rome, Italy
Pages: 3-9
|
Published online on: November 11, 2019

https://doi.org/10.3892/ijmm.2019.4401
Expand metrics +

Abstract

Polyamines are small positively charged alkylamines that are essential in a number of crucial eukaryotic processes, like normal cell growth and development. In normal physiological conditions, intracellular polyamine content is tightly regulated through a fine regulated network of biosynthetic and catabolic enzymes and a transport system. The dysregulation of this network is frequently associated to different tumors, where high levels of polyamines has been detected. Polyamines also modulate ion channels and ionotropic glutamate receptors and altered levels of polyamines have been observed in different brain diseases, including mental disorders and epilepsy. The goal of this article is to review the role of polyamines in mental disorders and epilepsy within a frame of the possible link between these two brain pathologies. The high comorbidity between these two neurological illnesses is strongly suggestive that they share a common background in the central nervous system. This review proposes an additional association between the noradrenalin/serotonin and glutamatergic neuronal circuits with polyamines. Polyamines can be considered supplementary defensive shielding molecules, important to protect the brain from the development of epilepsy and mental illnesses that are caused by different types of neurons. In this contest, the modulation of polyamine metabolism may be a novel important target for the prevention and therapeutic treatment of these diseases that have a high impact on the costs of public health and considerably affect quality of life.

View Figures

View References

1	Thomas T and Thomas TJ: Polyamines in cell growth and cell death: Molecular mechanisms and therapeutic applications. Cell Mol Life Sci. 58:244–258. 2001. View Article : Google Scholar : PubMed/NCBI
2	Rea G, Bocedi A and Cervelli M: Question: What is the biological function of the polyamines? IUBMB Life. 56:167–169. 2004.PubMed/NCBI
3	Wallace HM, Fraser AV and Hughes A: A perspective of poly-amine metabolism. Biochem J. 376:1–14. 2003. View Article : Google Scholar : PubMed/NCBI
4	Li G, Regunathan S and Reis DJ: Agmatine is synthesized by a mitochondrial arginine decarboxylase in rat brain. Ann N Y Acad Sci. 763:325–329. 1995. View Article : Google Scholar : PubMed/NCBI
5	Sastre M, Regunathan S, Galea E and Reis DJ: Agmatinase activity in rat brain: A metabolic pathway for the degradation of agmatine. J Neurochem. 67:1761–1765. 1996. View Article : Google Scholar : PubMed/NCBI
6	Moretti M, Matheus FC, de Oliveira PA, Neis VB, Ben J, Walz R, Rodrigues AL and Prediger RD: Role of agmatine in neurode-generative diseases and epilepsy. Front Biosci (Elite Ed). 6:341–359. 2014. View Article : Google Scholar
7	Cervelli M, Angelucci E, Stano P, Leboffe L, Federico R, Antonini G, Mariottini P and Polticelli F: The Glu²¹⁶/Ser²¹⁸ pocket is a major determinant of spermine oxidase substrate specificity. Biochem J. 461:453–459. 2014. View Article : Google Scholar : PubMed/NCBI
8	Cervelli M, Bellavia G, Fratini E, Amendola R, Polticelli F, Barba M, Federico R, Signore F, Gucciardo G, Grillo R, et al: Spermine oxidase (SMO) activity in breast tumor tissues and biochemical analysis of the anticancer spermine analogues BENSpm and CPENSpm. BMC Cancer. 10:5552010. View Article : Google Scholar : PubMed/NCBI
9	Cervelli M, Angelucci E, Germani F, Amendola R and Mariottini P: Inflammation, carcinogenesis and neurodegeneration studies in transgenic animal models for polyamine research. Amino Acids. 46:521–530. 2014. View Article : Google Scholar
10	Casero RA Jr, Murray Stewart T and Pegg AE: Polyamine metabolism and cancer: Treatments, challenges and opportunities. Nat Rev Cancer. 18:681–695. 2018. View Article : Google Scholar : PubMed/NCBI
11	Amendola R, Cervelli M, Fratini E, Polticelli F, Sallustio DE and Mariottini P: Spermine metabolism and anticancer therapy. Curr Cancer Drug Targets. 9:118–130. 2009. View Article : Google Scholar : PubMed/NCBI
12	Polticelli F, Salvi D, Mariottini P, Amendola R and Cervelli M: Molecular evolution of the polyamine oxidase gene family in Metazoa. BMC Evol Biol. 12:902012. View Article : Google Scholar : PubMed/NCBI
13	Cervelli M, Salvi D, Polticelli F, Amendola R and Mariottini P: Structure-function relationships in the evolutionary framework of spermine oxidase. J Mol Evol. 76:365–370. 2013. View Article : Google Scholar : PubMed/NCBI
14	Tavladoraki P, Cervelli M, Antonangeli F, Minervini G, Stano P, Federico R, Mariottini P and Polticelli F: Probing mammalian spermine oxidase enzyme-substrate complex through molecular modeling, site-directed mutagenesis and biochemical characterization. Amino Acids. 40:1115–1126. 2011. View Article : Google Scholar
15	Cervelli M, Polticelli F, Federico R and Mariottini P: Heterologous expression and characterization of mouse spermine oxidase. J Biol Chem. 278:5271–5276. 2003. View Article : Google Scholar
16	Cervelli M, Amendola R, Polticelli F and Mariottini P: Spermine oxidase: Ten years after. Amino Acids. 42:441–450. 2012. View Article : Google Scholar
17	Poulin R, Casero RA and Soulet D: Recent advances in the molecular biology of metazoan polyamine transport. Amino Acids. 42:711–723. 2012. View Article : Google Scholar
18	Abdulhussein AA and Wallace HM: Polyamines and membrane transporters. Amino Acids. 46:655–660. 2014. View Article : Google Scholar
19	Seiler N and Atanassov CL: The natural polyamines and the immune system. Prog Drug Res. 43:87–141. 1994.PubMed/NCBI
20	Mastrantonio R, Cervelli M, Pietropaoli S, Mariottini P, Colasanti M and Persichini T: HIV-Tat induces the Nrf2/ARE pathway through NMDA receptor-elicited spermine oxidase activation in human neuroblastoma cells. PLoS One. 11:e01498022016. View Article : Google Scholar : PubMed/NCBI
21	Igarashi K, Uemura T and Kashiwagi K: Acrolein: An effective biomarker for tissue damage produced from polyamines. Methods Mol Biol. 1694:459–468. 2018. View Article : Google Scholar
22	Pietropaoli S, Leonetti A, Cervetto C, Venturini A, Mastrantonio R, Baroli G, Persichini T, Colasanti M, Maura G, Marcoli M, et al: Glutamate excitotoxicity linked to spermine oxidase overexpression. Mol Neurobiol. 55:7259–7270. 2018. View Article : Google Scholar : PubMed/NCBI
23	Leonetti A, Baroli G, Fratini E, Pietropaoli S, Marcoli M, Mariottini P and Cervelli M: Epileptic seizures and oxidative stress in a mouse model overexpressing spermine oxidase. Amino Acids. Jun 13–2019.Epub ahead of print. View Article : Google Scholar
24	Skatchkova SN, Antonovb SM and Eatona MJ: Glia and glial polyamines. Role in brain function in health and disease. Biochemistry (Moscow) Suppl Ser A Membr Cell Biol. 10:73–98. 2016. View Article : Google Scholar
25	Oliver D, Baukrowitz T and Fakler B: Polyamines as gating molecules of inward-rectifier K⁺ channels. Eur J Biochem. 267:5824–5829. 2000. View Article : Google Scholar : PubMed/NCBI
26	Li J, Doyle KM and Tatlisumak T: Polyamines in the brain: Distribution, biological interactions, and their potential therapeutic role in brain ischaemia. Curr Med Chem. 14:1807–1813. 2007. View Article : Google Scholar : PubMed/NCBI
27	Williams K: Interactions of polyamines with ion channels. Biochem J. 325:289–297. 1997. View Article : Google Scholar : PubMed/NCBI
28	Pegg AE: Functions of polyamines in mammals. J Biol Chem. 291:14904–14912. 2016. View Article : Google Scholar : PubMed/NCBI
29	Williams K, Dawson VL, Romano C, Dichter MA and Molinoff PB: Characterization of polyamines having agonist, antagonist, and inverse agonist effects at the polyamine recognition site of the NMDA receptor. Neuron. 5:199–208. 1990. View Article : Google Scholar : PubMed/NCBI
30	Elsayed M and Magistretti PJ: A new outlook on mental illnesses: Glial involvement beyond the glue. Front Cell Neurosci. 9:4682015. View Article : Google Scholar
31	Sayers J: The world health report 2001-Mental health: New understanding, new hope. Bull World Health Organ. 79:10852001.
32	Merikangas KR, Nakamura EF and Kessler RC: Epidemiology of mental disorders in children and adolescents. Dialogues Clin Neurosci. 11:7–20. 2009.PubMed/NCBI
33	Kamal R, Cox C and Rousseau D: Kaiser Family Foundation: Costs and outcomes of mental health and substance use disorders in the US. JAMA. 318:4152017. View Article : Google Scholar
34	Mkrtchian A, Aylward J, Dayan P, Roiser JP and Robinson OJ: Modeling avoidance in mood and anxiety disorders using reinforcement learning. Biol Psychiatry. 82:532–539. 2017. View Article : Google Scholar : PubMed/NCBI
35	Benarous X, Consoli A, Cohen D, Renaud J, Lahaye H and Guilé JM: Suicidal behaviors and irritability in children and adolescents: A systematic review of the nature and mechanisms of the association. Eur Child Adolesc Psychiatry. 28:667–683. 2019. View Article : Google Scholar
36	Ferrúa CP, Giorgi R, da Rosa LC, do Amaral CC, Ghisleni GC, Pinheiro RT and Nedel F: MicroRNAs expressed in depression and their associated pathways: A systematic review and a bioin-formatics analysis. J Chem Neuroanat. 100:1016502019. View Article : Google Scholar
37	Furuyashiki T and Kitaoka S: Neural mechanisms underlying adaptive and maladaptive consequences of stress: Roles of dopaminergic and inflammatory responses. Psychiatry Clin Neurosci. Jun 19–2019.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
38	Jin Y, Sun LH, Yang W, Cui RJ and Xu SB: The role of BDNF in the neuroimmune axis regulation of mood disorders. Front Neurol. 10:5152019. View Article : Google Scholar : PubMed/NCBI
39	Peirce JM and Alviña K: The role of inflammation and the gut microbiome in depression and anxiety. J Neurosci Res. May 29–2019.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
40	Schildkraut JS: The catecholamine hypothesis of affective disorders: A review of supporting evidence. Am J Psychiatry. 122:509–522. 1965. View Article : Google Scholar : PubMed/NCBI
41	Whitaker-Azmitia PM: Serotonin and brain development: Role in human developmental diseases. Brain Res Bull. 56:479–485. 2001. View Article : Google Scholar : PubMed/NCBI
42	Liu Y, Zhao J, Fan X and Guo W: Dysfunction in serotonergic and noradrenergic systems and somatic symptoms in psychiatric disorders. Front Psychiatry. 10:2862019. View Article : Google Scholar : PubMed/NCBI
43	Fiori LM, Wanner B, Jomphe V, Croteau J, Vitaro F, Tremblay RE, Bureau A and Turecki G: Association of polyaminergic loci with anxiety, mood disorders, and attempted suicide. PLoS One. 5:e151462010. View Article : Google Scholar : PubMed/NCBI
44	Andrews RC: The side effects of antimalarial drugs indicates a polyamine involvement in both schizophrenia and depression. Med Hypotheses. 18:11–18. 1985. View Article : Google Scholar : PubMed/NCBI
45	Fiori LM and Turecki G: Implication of the polyamine system in mental disorders. J Psychiatry Neurosci. 33:102–110. 2008.PubMed/NCBI
46	Das I, de Belleroche J, Essali MA, Richardson-Andrews RC and Hirsch SR: Blood polyamine in schizophrenia. Schizophr Res. 2:1461989. View Article : Google Scholar
47	Meltzer HY, Arora RC, Jackman H, Pscheidt G and Smith MD: Platelet monoamine oxidase and plasma amine oxidase in psychiatric patients. Schizophr Bull. 6:213–219. 1980. View Article : Google Scholar : PubMed/NCBI
48	Baron M, Asnis L, Gruen R and Levitt M: Plasma amine oxidase and genetic vulnerability to schizophrenia. Arch Gen Psychiatry. 40:275–279. 1983. View Article : Google Scholar : PubMed/NCBI
49	Dahel KA, Al-Saffar NM and Flayeh KA: Polyamine oxidase activity in sera of depressed and schizophrenic patients after ECT treatment. Neurochem Res. 26:415–418. 2001. View Article : Google Scholar : PubMed/NCBI
50	Bernstein HG, Grecksch G, Becker A, Höllt V and Bogerts B: Cellular changes in rat brain areas associated with neonatal hippocampal damage. Neuroreport. 10:2307–2311. 1999. View Article : Google Scholar : PubMed/NCBI
51	Middleton FA, Mirnics K, Pierri JN, Lewis DA and Levitt P: Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci. 22:2718–2729. 2002. View Article : Google Scholar : PubMed/NCBI
52	He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C, Adamski J, Kahn R, Li Y, Illig T, et al: Schizophrenia shows a unique metabolomics signature in plasma. Trans Psychiatry. 2:e1492012. View Article : Google Scholar
53	Liu P, Jing Y, Collie ND, Dean B, Bilkey DK and Zhang H: Altered brain arginine metabolism in schizophrenia. Trans Psychiatry. 6:e8712016. View Article : Google Scholar
54	Genedani S, Saltini S, Benelli A, Filaferro M and Bertolini A: Influence of SAMe on the modifications of brain polyamine levels in an animal model of depression. Neuroreport. 12:3939–3942. 2001. View Article : Google Scholar : PubMed/NCBI
55	Reis DJ and Regunathan S: Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci. 21:187–193. 2000. View Article : Google Scholar : PubMed/NCBI
56	Askalany AR, Yamakura T, Petrenko AB, Kohno T, Sakimura K and Baba H: Effect of agmatine on heteromeric N-methyl-D-aspartate receptor channels. Neurosci Res. 52:387–392. 2005. View Article : Google Scholar : PubMed/NCBI
57	Gross JA and Turecki G: Suicide and the polyamine system. CNS Neurol Disord Drug Targets. 12:980–988. 2013. View Article : Google Scholar : PubMed/NCBI
58	Turecki G: Polyamines and suicide risk. Mol Psychiatry. 18:1242–1243. 2013. View Article : Google Scholar : PubMed/NCBI
59	Naseer MI, Ullah I, Al-Qahtani MH, Karim S, Ullah N, Ansari SA, Kim MO and Bibi F: Decreased GABABR expression and increased neuronal cell death in developing rat brain after PTZ-induced seizure. Neurol Sci. 34:497–503. 2013. View Article : Google Scholar
60	Hauser WA and Kurland RT: The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia. 16:1–66. 1975. View Article : Google Scholar : PubMed/NCBI
61	Genton P and Bureau M: Epilepsy with myoclonic absences. CNS Drugs. 20:911–916. 2006. View Article : Google Scholar : PubMed/NCBI
62	Téllez-Zenteno JF and Hernández-Ronquillo L: A review of the epidemiology of temporal lobe epilepsy. Epilepsy Res Treat. 2012:6308532012.PubMed/NCBI
63	Halmekytö M, Alhonen L, Wahlfors J, Sinervirta R, Eloranta T and Jänne J: Characterization of a transgenic mouse line over-expressing the human ornithine decarboxylase gene. Biochem J. 278:895–898. 1991. View Article : Google Scholar : PubMed/NCBI
64	Halonen T, Sivenius J, Miettinen R, Halmekytö M, Kauppinen R, Sinervirta R, Alakuijala L, Alhonen L, MacDonald E and Jänne J: Elevated seizure threshold and impaired spatial learning in transgenic mice with putrescine overproduction in the brain. Eur J Neurosci. 5:1233–1239. 1993. View Article : Google Scholar : PubMed/NCBI
65	Lukkarinen JA, Kauppinen RA, Gröhn OH, Oja JM, Sinervirta R, Järvinen A, Alhonen LI and Jänne J: Neuroprotective role of ornithine decarboxylase activation in transient focal cerebral ischaemia: A study using ornithine decarboxylase-overexpressing transgenic rats. Eur J Neurosci. 10:2046–2055. 1998. View Article : Google Scholar : PubMed/NCBI
66	Pietilä M, Alhonen L, Halmekytö M, Kanter P, Jänne J and Porter CW: Activation of polyamine catabolism profoundly alters tissue polyamine pools and affects hair growth and female fertility in transgenic mice overexpressing spermidine/spermine N1-acetyltransferase. J Biol Chem. 272:18746–18751. 1997. View Article : Google Scholar : PubMed/NCBI
67	Kaasinen K, Koistinaho J, Alhonen L and Jänne J: Overexpression of spermidine/spermine N-acetyltransferase in transgenic mice protects the animals from kainate-induced toxicity. Eur J Neurosci. 12:540–548. 2000. View Article : Google Scholar : PubMed/NCBI
68	Kaasinen SK, Gröhn OH, Keinänen TA, Alhonen L and Jänne J: Overexpression of spermidine/spermine N1-acetyltransferase elevates the threshold to pentylenetetrazol-induced seizure activity in transgenic mice. Exp Neurol. 183:645–652. 2003. View Article : Google Scholar : PubMed/NCBI
69	Kaasinen SK, Oksman M, Alhonen L, Tanila H and Jänne J: Spermidine/spermine N1-acetyltransferase overexpression in mice induces hypoactivity and spatial learning impairment. Pharmacol Biochem Behav. 78:35–45. 2004. View Article : Google Scholar : PubMed/NCBI
70	Cervelli M, Bellavia G, D'Amelio M, Cavallucci V, Moreno S, Berger J, Nardacci R, Marcoli M, Maura G, Piacentini M, et al: A new transgenic mouse model for studying the neurotoxicity of spermine oxidase dosage in the response to excitotoxic injury. PLoS One. 8:e648102013. View Article : Google Scholar : PubMed/NCBI
71	Cervetto C, Vergani L, Passalacqua M, Ragazzoni M, Venturini A, Cecconi F, Berretta N, Mercuri N, D'Amelio M, Maura G, et al: Astrocyte-dependent vulnerability to excitotoxicity in spermine oxidase-overexpressing mouse. Neuromolecular Med. 18:50–68. 2016. View Article : Google Scholar
72	Alhonen L, Uimari A, Pietilä M, Hyvönen MT, Pirinen E and Keinänen TA: Transgenic animals modelling polyamine metabolism-related diseases. Essays Biochem. 46:125–144. 2009. View Article : Google Scholar
73	Fleidervish IA, Libman L, Katz E and Gutnick MJ: Endogenous polyamines regulate cortical neuronal excitability by blocking voltage-gated Na⁺ channels. Proc Natl Acad Sci USA. 105:18994–18999. 2008. View Article : Google Scholar
74	Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ and Dingledine R: Glutamate receptor ion channels: Structure, regulation, and function. Pharmacol Rev. 62:405–496. 2010. View Article : Google Scholar : PubMed/NCBI
75	Jänne J, Alhonen L, Pietilä M and Keinänen TA: Genetic approaches to the cellular functions of polyamines in mammals. Eur J Biochem. 271:877–894. 2004. View Article : Google Scholar : PubMed/NCBI
76	Chapouthier G and Venault P: A pharmacological link between epilepsy and anxiety? Trends Pharmacol Sci. 22:491–493. 2001. View Article : Google Scholar : PubMed/NCBI
77	Harden CL and Goldstein MA: Mood disorders in patients with epilepsy: Epidemiology and management. CNS Drugs. 16:291–302. 2002. View Article : Google Scholar : PubMed/NCBI
78	Kanner AM: Epilepsy and mood disorders. Epilepsia. 48:20–22. 2007. View Article : Google Scholar : PubMed/NCBI
79	Stahl SM: Brainstorms: Symptoms and circuits, part 2: Anxiety disorders. J Clin Psychiatry. 64:1408–1409. 2003. View Article : Google Scholar
80	Jackson MJ and Turkington D: Depression and anxiety in epilepsy. J Neurol Neurosurg Psychiatry. 76(Suppl 1): i45–i47. 2005. View Article : Google Scholar : PubMed/NCBI
81	Aroniadou-Anderjaska V, Qashu F and Braga MF: Mechanisms regulating GABAergic inhibitory transmission in the basolateral amygdala: Implications for epilepsy and anxiety disorders. Amino Acids. 32:305–315. 2007. View Article : Google Scholar
82	Hamid H, Ettinger AB and Mula M: Anxiety symptoms in epilepsy: Salient issues for future research. Epilepsy Behav. 22:63–68. 2011. View Article : Google Scholar : PubMed/NCBI
83	Gaitatzis A, Carroll K, Majeed A and W Sander J: The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia. 45:1613–1622. 2004. View Article : Google Scholar : PubMed/NCBI
84	Rogawski MA and Löscher W: The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med. 10:685–692. 2004. View Article : Google Scholar : PubMed/NCBI
85	Pitkänen A and Sutula TP: Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol. 1:173–181. 2002. View Article : Google Scholar
86	Mula M, Pini S and Cassano GB: The role of anticonvulsant drugs in anxiety disorders: A critical review of the evidence. J Clin Psychopharmacol. 27:263–272. 2007. View Article : Google Scholar : PubMed/NCBI
87	Hitiris N, Mohanraj R, Norrie J, Sills GJ and Brodie MJ: Predictors of pharmacoresistant epilepsy. Epilepsy Res. 75:192–196. 2007. View Article : Google Scholar : PubMed/NCBI
88	Kanner AM: Psychiatric issues in epilepsy: The complex relation of mood, anxiety disorders, and epilepsy. Epilepsy Behav. 15:83–87. 2009. View Article : Google Scholar : PubMed/NCBI
89	Theodore WH: Does serotonin play a role in epilepsy? Epilepsy Curr. 3:173–177. 2003. View Article : Google Scholar
90	Richerson GB: Serotonin: The anti-sudden death amine? Epilepsy Curr. 13:241–244. 2013. View Article : Google Scholar : PubMed/NCBI
91	Maia GH, Soares JI, Almeida SG, Leite JM, Baptista HX, Lukoyanova AN, Brazete CS and Lukoyanov NV: Altered serotonin innervation in the rat epileptic brain. Brain Res Bull. 152:95–106. 2019. View Article : Google Scholar : PubMed/NCBI
92	Jobe PC and Browning RA: The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant. Epilepsy Behav. 7:602–619. 2005. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Polyamines: The possible missing link between mental disorders and epilepsy (Review)

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Related Articles